Ebola Shots on Lake Geneva for $845 Test Vaccine Support

Lock
This article is for subscribers only.

Lausanne, Switzerland, is known for its fine restaurants, terraced vineyards, graceful streets that spill down the mountainside to Lake Geneva -- and, starting Oct. 31, the willingness of at least some citizens to be injected with a piece of the Ebola virus.

The city will host the largest study for the leading experimental vaccine to fight Ebola, a key step in halting the outbreak. Though its sedate streets are far from the contagion in West Africa, the scientist leading the tests says he’s managed to find a first batch of willing participants -- albeit mostly doctors and medical students.